Literature DB >> 25749018

Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients.

Ghanshyam N Pandey1, Xinguo Ren2, Hooriyah S Rizavi2, Hui Zhang2.   

Abstract

Abnormalities of protein levels of proinflammatory cytokines and their soluble receptors have been reported in the plasma/serum of schizophrenia (SZ) patients. To examine if SZ is also associated with the abnormal gene expression of cytokines and their membrane-bound receptors, we studied mRNA expression of proinflammatory cytokines and their receptors in lymphocytes of SZ patients and normal control (NC) subjects. We determined the protein and mRNA expression of proinflammatory cytokines and mRNA expression of their receptors in lymphocytes from 30 SZ patients and 30 drug-free NC subjects. The subjects were diagnosed according to DSM-IV criteria. Protein levels of cytokines were determined by ELISA, and mRNA levels in lymphocytes were determined by the qPCR method. We found that the mRNA levels of IL-6, TNF-α, IL-1R1, TNFR1, and TNFR2, but not IL-1β, IL-1R2, IL-1RA, IL-6R, or GP130 were significantly increased in lymphocytes of SZ patients compared with NC subjects. We also found that the protein expression of IL-6 and TNF-α, but not IL-1β, was also significantly increased in SZ patients compared with NC subjects. These studies suggest that in addition to the reported abnormalities of proinflammatory cytokines and their soluble receptors in the plasma of SZ patients, an abnormal gene expression of these cytokines and their membrane-bound receptors may be involved in the pathogenesis of SZ.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Gp130; IL-1R1; IL-1R2; IL-1RA; IL-1β; IL-6; IL-6R; Lymphocytes; Proinflammatory cytokines; Schizophrenia; TNF-α; TNFR1; TNFR2

Mesh:

Substances:

Year:  2015        PMID: 25749018      PMCID: PMC4940115          DOI: 10.1016/j.schres.2015.02.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

Review 1.  Inflammatory cytokine network in schizophrenia.

Authors:  Roksana Zakharyan; Anna Boyajyan
Journal:  World J Biol Psychiatry       Date:  2013-09-16       Impact factor: 4.132

2.  Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.

Authors:  B Dean; A S Gibbons; N Tawadros; L Brooks; I P Everall; E Scarr
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

Review 3.  The cytokine model of schizophrenia: emerging therapeutic strategies.

Authors:  Ragy R Girgis; Samhita S Kumar; Alan S Brown
Journal:  Biol Psychiatry       Date:  2013-12-11       Impact factor: 13.382

4.  Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

Authors:  L Capuron; A Ravaud; R Dantzer
Journal:  Psychosom Med       Date:  2001 May-Jun       Impact factor: 4.312

Review 5.  Interleukin-6 biology is coordinated by membrane bound and soluble receptors.

Authors:  Stefan Rose-John
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

Review 6.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

7.  Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.

Authors:  Sigrun Hope; Ingrid Melle; Pål Aukrust; Nils Eiel Steen; Astrid B Birkenaes; Steinar Lorentzen; Ingrid Agartz; Thor Ueland; Ole A Andreassen
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

8.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

Review 9.  The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.

Authors:  Kyoung-Sae Na; Han-Yong Jung; Yong-Ku Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-11-01       Impact factor: 5.067

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  11 in total

1.  A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Authors:  Eva Zsuzsanna Hoseth; Thor Ueland; Ingrid Dieset; Rebecca Birnbaum; Joo Heon Shin; Joel Edward Kleinman; Thomas Michael Hyde; Ragni Helene Mørch; Sigrun Hope; Tove Lekva; Aurelija Judita Abraityte; Annika E Michelsen; Ingrid Melle; Lars Tjelta Westlye; Torill Ueland; Srdjan Djurovic; Pål Aukrust; Daniel R Weinberger; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Cognitive endophenotypes inform genome-wide expression profiling in schizophrenia.

Authors:  Amanda B Zheutlin; Rachael W Viehman; Rebecca Fortgang; Jacqueline Borg; Desmond J Smith; Jaana Suvisaari; Sebastian Therman; Christina M Hultman; Tyrone D Cannon
Journal:  Neuropsychology       Date:  2016-01       Impact factor: 3.295

3.  Cytokines as Suicide Risk Biomarkers.

Authors:  Ghanshyam N Pandey
Journal:  Biol Psychiatry       Date:  2015-07-01       Impact factor: 13.382

4.  Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.

Authors:  Veronica L Hood; Ralph Berger; Robert Freedman; Amanda J Law
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

5.  Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.

Authors:  John Abel Engh; Thor Ueland; Ingrid Agartz; Dimitrios Andreou; Pål Aukrust; Birgitte Boye; Erlend Bøen; Ole Kristian Drange; Torbjørn Elvsåshagen; Sigrun Hope; Margrethe Collier Høegh; Inge Joa; Erik Johnsen; Rune Andreas Kroken; Trine Vik Lagerberg; Tove Lekva; Ulrik Fredrik Malt; Ingrid Melle; Gunnar Morken; Terje Nærland; Vidar Martin Steen; Kirsten Wedervang-Resell; Melissa Auten Weibell; Lars Tjelta Westlye; Srdjan Djurovic; Nils Eiel Steen; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 6.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

7.  Association Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population.

Authors:  Renata Suchanek-Raif; Krzysztof Kucia; Małgorzata Kowalczyk; Paweł Raif; Monika Paul-Samojedny; Anna Fila-Daniłow; Jan Kowalski
Journal:  Mediators Inflamm       Date:  2017-11-29       Impact factor: 4.711

Review 8.  The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders.

Authors:  João P Luís; Carlos J V Simões; Rui M M Brito
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

9.  Transcriptome Profiling Reveals Novel Candidate Genes Related to Hippocampal Dysfunction in SREBP-1c Knockout Mice.

Authors:  Mary Jasmin Ang; Juhwan Kim; Sueun Lee; Sung-Ho Kim; Jong-Choon Kim; Tae-Il Jeon; Seung-Soon Im; Changjong Moon
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

10.  Polymorphic Variants of TNFR2 Gene in Schizophrenia and Its Interaction with -308G/A TNF-α Gene Polymorphism.

Authors:  Renata Suchanek-Raif; Paweł Raif; Małgorzata Kowalczyk; Monika Paul-Samojedny; Krzysztof Kucia; Wojciech Merk; Jan Kowalski
Journal:  Mediators Inflamm       Date:  2018-09-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.